Ever Supreme Bio Technology Co., Ltd.

7 clinical trials · Sponsor

Record	Firm	Date
A Safety and Efficacy Study of Allogeneic CAR Gamma-Delta T Cells in Subjects with Relapsed/Refractory Solid Tumors (NCT06150885)	Ever Supreme Bio Technology Co., Ltd.	2024-09-01
Evaluate the Efficacy and Safety of Allogeneic Umbilical Cord Mesenchymal Stem Cells As an Add-On Treatment for Acute ST-elevation Myocardial Infarction (STEMI) Patients (NCT06147986)	Ever Supreme Bio Technology Co., Ltd.	2023-09-24
Evaluate the Safety and Efficacy of Allogeneic Umbilical Cord Mesenchymal Stem Cells in Patients With Multiple Sclerosis (NCT05532943)	Ever Supreme Bio Technology Co., Ltd.	2023-09-08
Evaluate the Safety and Explore Efficacy of Umbilical Cord Mesenchymal Stem Cells in Acute Ischemic Stroke (NCT04434768)	Ever Supreme Bio Technology Co., Ltd.	2020-12-02
Evaluate the Safety and Efficacy of Allogeneic Umbilical Cord Mesenchymal Stem Cells in Patients With COVID-19 (NCT05501418)	Ever Supreme Bio Technology Co., Ltd.	2020-08-05
Evaluate the Efficacy and Safety of ADCV01 As an Add-On Treatment for Primary Glioblastoma Multiforme (GBM) Patients (NCT04115761)	Ever Supreme Bio Technology Co., Ltd.	2019-06-06
Evaluate the Safety and Explore Efficacy of Umbilical Cord Mesenchymal Stem Cells in Acute Myocardial Infarction (NCT04056819)	Ever Supreme Bio Technology Co., Ltd.	2019-05-27

Every clearance here is in the API, with alerts when new ones post.